Xceleron Receives the Award for International Achievement at Yorkshire Bioscience Awards
Complete the form below to unlock access to ALL audio articles.
Xceleron has announced it has won the Yorkshire Bioscience Award for International Achievement.
The award, organized by Yorkshire Forward, recognizes and rewards companies for leading innovation and achievement in the region’s growing bioscience sector.
Xceleron was recognized for its recent achievements overseas following the establishment of its subsidiary in the US and the growth of its customer base in both Europe and Japan.
Professor Colin Garner, Chief Executive Officer, commented, "We are extremely pleased to receive this award. It’s a fantastic achievement and I’d like to thank everyone at Xceleron for their contribution."
"Our aim is to continue to build a leading international business using our pioneering technology to benefit the global pharmaceutical industry and bring new medicines to people more quickly."
The company’s approach facilitates Phase 0 early human trials to identify the metabolic fate of a drug at the single molecule level.
To date, studies have consistently shown data linearity between Phase 0 microdosing and traditional Phase I PK measures.
